1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Sacituzumab govitecan for untreated PD-L1-negative triple-negative advanced breast cancer ID6433

Awaiting development [GID-TA11489] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN:29304-Sacituzumab-Govitecan-for-Breast-Cancer-V1.0-NOV2023-NON-CONF.pdf (nihr.ac.uk)